Security key
25253X207
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Voting Common Shares, no par value
- Total 13F shares
- 4,824
- Total 13F value
- $33,961
- Share change
- 0
- SEC-reported price per share
- $7.04
- Number of holders
- 1
- Shares outstanding
- 52,272,727
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
2
DMAC full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
DiaMedica Therapeutics Inc. SEC filings
DiaMedica Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25253X207
Recent filing periods:
Ownership snapshot
Top reported holders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TRILL AB
Disclosed value leader
Jan Stahlberg
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 17%
13D/G row: TRILL AB
Showing 1-6 of 15 holder rows.
Quick read
TRILL AB leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TRILL AB's linked filing trail.
Comparable ownership
Top 5
TRILL AB
17%
TomEnterprise AB
16%
Richard Jacinto II
9.6%
Leon G. Cooperman
6.6%
Jan Stahlberg
17%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TRILL AB |
13D/G
|
17%
|
$70,252,906
8,825,742 shares
|
+$8,447,765 | 31 Dec 2025 |
| TomEnterprise AB |
13D/G
|
16%
|
$32,695,950
8,383,577 shares
|
$0 | 23 Jul 2025 |
| Richard Jacinto II |
13D/G
3/4/5
10%+ Owner
|
9.6%
|
$34,067,114
4,958,823 shares
|
$0 | 30 Sep 2025 |
| Leon G. Cooperman |
13D/G
13F
Cooperman Leon G. · Individual
|
6.6%
|
$28,462,500
3,450,000 shares
|
+$1,486,972 | 31 Dec 2025 |
| Jan Stahlberg |
3/4/5
10%+ Owner
|
17%
|
$75,679,855
8,825,742 shares
|
+$18,989,576 | 17 Nov 2025 |
| Thomas von Koch |
3/4/5
10%+ Owner
|
16%
|
$29,342,519
8,383,577 shares
|
+$9,999,997 | 23 Jul 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
4,824
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
98
Q2 2026 holders
1
Holder diff
-97
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend